Shuttle Pharmaceuticals raises $2.5M via private placement of pre-funded warrants

Shuttle Pharmaceuticals Holdings, Inc.

Pre-funded warrant for 625,156 shares at $0.001 exercise price, immediately exercisable.
Gross proceeds $2.5M; placement agent WestPark Capital paid 4% cash fee.
Closing on Nov 4, 2025; resale registration statement due within 15 days.
Beneficial ownership limited to 4.99% (can increase to 9.99% with 61 days notice).

Key facts

Extracted from this filing and checked against the source text.

Equity Issuances SEC 8-K Item 3.02/3.03 confidence 0.9

Shuttle Pharmaceuticals Holdings, Inc. issued up to 625,156 shares of common stock of warrant to the Purchaser for aggregate gross proceeds of approximately $2.5 million.

Security: warrant
Shares: up to 625,156 shares of common stock
Purchaser: the Purchaser
Consideration: aggregate gross proceeds of approximately $2.5 million

Exact text from the filing

to purchase up to 625,156 shares of common stock of the Company, par value $0.00001 per share (the “Common Stock”) for aggregate gross proceeds of approximately $2.5 million, before deducting placement agent fees to WestPark Capital, Inc. (the “Placement Agent”) and offering expenses payable by the Company. The Offering closed on November 4, 2025.

View on SEC.gov

Browse all equity issuances →

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-25-021256

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.